Everything I read about Essa Pharma (NASDAQ: EPIX) sounds positive. They claim to have a game-changing prostate cancer technology and significant news ahead. But it is very difficult to buys shares because the 1M float seems tightly held. Four institutions (BVF, Clarus, Omega, Eventide) own 90% of common paid well over $12 for their shares, an analyst has a 24/share price target, and it's funded to 2020. Please help me understand its technical setup because fundamentals seem strong but I don't know much about technical analysis. Thank you!